Aesthetic Financial Statements From 2010 to 2022

AIH
 Stock
  

USD 2.35  0.10  4.44%   

Aesthetic Medical financial statements provide useful quarterly and yearly information to potential Aesthetic Medical International investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Aesthetic Medical financial statements helps investors assess Aesthetic Medical's valuation, profitability, and current liquidity needs.
We have found seventy-seven available fundamental signals for Aesthetic Medical International, which can be analyzed and compared to other ratios and to its rivals. Please verify all of Aesthetic Medical International prevailing fundamental drivers against the trend between 2010 and 2022 to make sure the company can sustain itself down the road.
Aesthetic Medical Free Cash Flow is most likely to decrease significantly in the upcoming years. The last year's value of Free Cash Flow was reported at 18.64 Million. The current Invested Capital is estimated to increase to about 469.9 M, while Earnings Before Interest Taxes and Depreciation Amortization EBITDA are projected to decrease to (586.2 M).
  
Check Aesthetic Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aesthetic main balance sheet or income statement drivers, such as Cost of Revenue of 363.8 M, Gross Profit of 334.2 M or Interest Expense of 23.9 M, as well as many exotic indicators such as Asset Turnover of 0.83, Current Ratio of 0.22 or Free Cash Flow per Share of 0.85. Aesthetic financial statements analysis is a perfect complement when working with Aesthetic Medical Valuation or Volatility modules. It can also supplement various Aesthetic Medical Technical models . Please continue to the analysis of Aesthetic Medical Correlation against competitors.

Aesthetic Medical Revenues

770.11 Million

Aesthetic Medical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets757.2 M576.9 M670.7 M
Increasing
Slightly volatile
Cash and Equivalents58.9 M39.3 M96.2 M
Decreasing
Slightly volatile
InvestmentsM4.9 M29.2 M
Decreasing
Slightly volatile
Investments Non CurrentM4.9 M29.2 M
Decreasing
Slightly volatile
Deferred Revenue255.1 M236.5 M42.5 M
Increasing
Slightly volatile
Property Plant and Equipment Net413 M358.7 M303.7 M
Increasing
Slightly volatile
Inventory31.9 M30.6 M26.4 M
Increasing
Slightly volatile
Tax Assets38.1 M45.8 M18.7 M
Increasing
Slightly volatile
Trade and Non Trade Receivables12.5 M12.2 M37.5 M
Decreasing
Slightly volatile
Trade and Non Trade Payables32.4 M31.7 M28.5 M
Increasing
Very volatile
Goodwill and Intangible Assets38.2 M37.2 M78.6 M
Increasing
Stable
Total Liabilities790.6 M763.4 M642.4 M
Increasing
Slightly volatile
Shareholders Equity(160.8 M)(156.7 M)(2.5 M)
Increasing
Stable
Current Assets151.3 M113.7 M215.5 M
Decreasing
Slightly volatile
Assets Non Current571.5 M463.2 M452.6 M
Increasing
Slightly volatile
Current Liabilities448.3 M541.7 M213.7 M
Increasing
Slightly volatile
Liabilities Non Current280.8 M221.7 M423.9 M
Decreasing
Slightly volatile
Tax Liabilities13.7 M9.3 M19.9 M
Decreasing
Stable
Total Debt421.9 M405.9 M298 M
Increasing
Slightly volatile
Debt Current168.8 M184.5 M72.5 M
Increasing
Slightly volatile
Debt Non Current253.1 M221.4 M225.6 M
Increasing
Slightly volatile
Shareholders Equity USD(25.1 M)(24.5 M)(660.3 K)
Increasing
Stable
Cash and Equivalents USD8.9 M6.1 M14.4 M
Decreasing
Slightly volatile
Total Debt USD64.6 M63.4 M44.9 M
Increasing
Slightly volatile

Aesthetic Medical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Revenues770.1 M645.6 M672.2 M
Increasing
Slightly volatile
Cost of Revenue363.8 M376.1 M260.5 M
Increasing
Slightly volatile
Selling General and Administrative Expense626.6 M611.7 M454 M
Increasing
Slightly volatile
Operating Expenses817.6 M919.5 M491 M
Increasing
Slightly volatile
Interest Expense23.9 M27.2 M10.8 M
Increasing
Slightly volatile
Income Tax Expense(12.1 M)(11.8 M)8.6 M
Decreasing
Slightly volatile
Consolidated Income(687.1 M)(669.5 M)(110.5 M)
Decreasing
Slightly volatile
Net Income to Non Controlling Interests(85.1 M)(82.9 M)(13 M)
Decreasing
Slightly volatile
Net Income(602.1 M)(586.6 M)(97.5 M)
Decreasing
Slightly volatile
Net Income Common Stock(602.1 M)(586.6 M)(97.5 M)
Decreasing
Slightly volatile
Weighted Average Shares67.1 M70.8 M70.5 M
Decreasing
Slightly volatile
Earning Before Interest and Taxes EBIT(586.2 M)(571.2 M)(77.8 M)
Decreasing
Slightly volatile
Revenues USD117.1 M100.9 M99.1 M
Increasing
Slightly volatile
Net Income Common Stock USD(94.1 M)(91.7 M)(15.4 M)
Decreasing
Slightly volatile
Earning Before Interest and Taxes USD(91.6 M)(89.2 M)(12.5 M)
Decreasing
Slightly volatile
Gross Profit334.2 M269.5 M406.1 M
Increasing
Stable
Operating Income(667.1 M)(650 M)(99 M)
Decreasing
Slightly volatile

Aesthetic Medical Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Net Cash Flow Business Acquisitions and Disposals(7.6 M)(7.1 M)(32.3 M)
Increasing
Slightly volatile
Net Cash Flow Investment Acquisitions and Disposals21.6 M20 M(17.2 M)
Increasing
Slightly volatile
Net Cash Flow from Financing(46.4 M)(45.2 M)35 M
Decreasing
Slightly volatile
Issuance Repayment of Debt Securities (32.1 M)(31.3 M)31.9 M
Decreasing
Slightly volatile
Issuance Purchase of Equity Shares(1.8 M)(1.8 M)31.4 M
Increasing
Very volatile
Net Cash Flow from Operations51.3 M51.7 M56.9 M
Decreasing
Stable
Effect of Exchange Rate Changes on Cash 619.3 K574 K(1.5 M)
Increasing
Slightly volatile
Net Cash Flow or Change in Cash and Cash Equivalents(5.8 M)(5.7 M)31.4 M
Decreasing
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Earnings per Basic Share(27.37)(26.67)(4.1872)
Decreasing
Slightly volatile
Earnings per Diluted Share(27.37)(26.67)(7.0049)
Decreasing
Slightly volatile
Earnings per Basic Share USD(4.28)(4.167)(0.6642)
Decreasing
Slightly volatile
Return on Average Equity(5.14)(5.009)0.3436
Decreasing
Slightly volatile
Return on Average Assets(0.75)(0.726)(0.399)
Decreasing
Very volatile
Return on Invested Capital(0.9)(0.879)(0.399)
Decreasing
Stable
Gross Margin0.480.4170.6077
Decreasing
Slightly volatile
Profit Margin(0.93)(0.909)(0.1375)
Decreasing
Slightly volatile
EBITDA Margin(0.91)(0.885)(0.1078)
Decreasing
Slightly volatile
Return on Sales(0.91)(0.885)(0.1078)
Decreasing
Slightly volatile
Asset Turnover0.830.7991.1051
Decreasing
Slightly volatile
Enterprise Value over EBITDA(1.62)(1.578)5.9215
Decreasing
Slightly volatile
Enterprise Value over EBIT(2.05)(2.0)6.1498
Decreasing
Slightly volatile
Price to Earnings Ratio(0.86)(0.835)3.5183
Decreasing
Slightly volatile
Sales per Share4.364.2754.7481
Increasing
Stable
Price to Sales Ratio0.840.8141.1358
Decreasing
Slightly volatile
Price to Book Value(3.44)(3.355)1.1279
Decreasing
Slightly volatile
Debt to Equity Ratio(5.26)(4.873)(8.7324)
Increasing
Slightly volatile
Current Ratio0.220.211.3342
Decreasing
Slightly volatile
Free Cash Flow per Share0.850.79(1.2579)
Increasing
Slightly volatile
Book Value per Share(6.82)(6.639)(6.1409)
Increasing
Slightly volatile
Tangible Assets Book Value per Share24.7422.87127.0556
Increasing
Stable

Aesthetic Medical Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Earnings before Tax(614.2 M)(598.4 M)(88.9 M)
Decreasing
Slightly volatile
Earnings Before Interest Taxes and Depreciation Amortization EBITDA(586.2 M)(571.2 M)(77.8 M)
Decreasing
Slightly volatile
Earnings Before Interest Taxes and Depreciation Amortization USD(91.6 M)(89.2 M)(12.5 M)
Decreasing
Slightly volatile
Market Capitalization93.5 M82.1 M139.7 M
Decreasing
Slightly volatile
Enterprise Value153.1 M140.8 M204.2 M
Decreasing
Slightly volatile
Invested Capital469.9 M364.7 M567.7 M
Increasing
Stable
Average Equity140.4 M117.1 M(47.4 M)
Increasing
Slightly volatile
Average Assets918.9 M807.5 M719.2 M
Increasing
Slightly volatile
Invested Capital Average760.6 M650.2 M652.1 M
Increasing
Slightly volatile
Tangible Asset Value673.8 M539.7 M588.7 M
Increasing
Slightly volatile
Free Cash Flow20.1 M18.6 M13.4 M
Decreasing
Stable
Working Capital(439.2 M)(427.9 M)(9.2 M)
Decreasing
Slightly volatile

Aesthetic Fundamental Market Drivers

Forward Price Earnings5.22
Shares Short Prior Month67.75k
Average Daily Volume Last 10 Day11.78k
Average Daily Volume In Three Month21.96k
Date Short Interest15th of July 2022
Fifty Day Average2.0154
Two Hundred Day Average2.5955

Aesthetic Upcoming Events

Upcoming Quarterly Report19th of April 2022
Next Fiscal Quarter End31st of December 2021
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

About Aesthetic Medical Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Aesthetic Medical income statement, its balance sheet, and the statement of cash flows. Aesthetic Medical investors use historical funamental indicators, such as Aesthetic Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Aesthetic Medical investors may use each financial statement separately, they are all related. The changes in Aesthetic Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Aesthetic Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Aesthetic Medical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Aesthetic Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Deferred Revenue236.5 M255.1 M
Cost of Revenue376.1 M363.8 M
Revenues645.6 M770.1 M
Aesthetic Medical International Holdings Group Limited provides aesthetic medical services. Aesthetic Medical International Holdings Group Limited was founded in 1997 and is headquartered in Shenzhen, the Peoples Republic of China. Aesthetic Medical operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 1451 people.

Aesthetic Medical Investors Sentiment

The influence of Aesthetic Medical's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Aesthetic. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Aesthetic Medical's public news can be used to forecast risks associated with investment in Aesthetic. The trend in average sentiment can be used to explain how an investor holding Aesthetic can time the market purely based on public headlines and social activities around Aesthetic Medical International. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Aesthetic Medical's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Aesthetic Medical's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Aesthetic Medical's news discussions. The higher the estimate score, the more favorable is the investor's outlook on Aesthetic Medical.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Aesthetic Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Aesthetic Medical's short interest history, or implied volatility extrapolated from Aesthetic Medical options trading.

Pair Trading with Aesthetic Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aesthetic Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aesthetic Medical will appreciate offsetting losses from the drop in the long position's value.

Moving together with Aesthetic Medical

0.61AMNAmn Healthcare Services Upward RallyPairCorr

Moving against Aesthetic Medical

0.69IONMAssure Holdings Corp Earnings Call  Next WeekPairCorr
0.69ACHVAchieve Life Sciences Earnings Call  This WeekPairCorr
0.68ACSTAcasti Pharma Earnings Call  This WeekPairCorr
0.65ABVCAbvc Biopharma Earnings Call  This WeekPairCorr
The ability to find closely correlated positions to Aesthetic Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aesthetic Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aesthetic Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aesthetic Medical International to buy it.
The correlation of Aesthetic Medical is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aesthetic Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aesthetic Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aesthetic Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to the analysis of Aesthetic Medical Correlation against competitors. Note that the Aesthetic Medical information on this page should be used as a complementary analysis to other Aesthetic Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Complementary Tools for Aesthetic Stock analysis

When running Aesthetic Medical price analysis, check to measure Aesthetic Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aesthetic Medical is operating at the current time. Most of Aesthetic Medical's value examination focuses on studying past and present price action to predict the probability of Aesthetic Medical's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Aesthetic Medical's price. Additionally, you may evaluate how the addition of Aesthetic Medical to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Is Aesthetic Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aesthetic Medical. If investors know Aesthetic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aesthetic Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
12.19
Market Capitalization
72.2 M
Quarterly Revenue Growth YOY
0.19
Return On Assets
-0.2
Return On Equity
-4.92
The market value of Aesthetic Medical is measured differently than its book value, which is the value of Aesthetic that is recorded on the company's balance sheet. Investors also form their own opinion of Aesthetic Medical's value that differs from its market value or its book value, called intrinsic value, which is Aesthetic Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aesthetic Medical's market value can be influenced by many factors that don't directly affect Aesthetic Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aesthetic Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine Aesthetic Medical value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aesthetic Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.